There is no minimum age for getting shingles. Anyone who has had chickenpox or received the chickenpox vaccine can develop shingles, from infants to the very elderly. That said, the risk climbs steeply after age 50, and most cases cluster in people over 60. The real question isn’t whether young people can get shingles but why the disease overwhelmingly targets older adults and what that means for everyone else.
Why Shingles Is Linked to Age
Shingles happens when the varicella-zoster virus, the same virus that causes chickenpox, wakes up after lying dormant in nerve cells, sometimes for decades. After a childhood bout of chickenpox, the virus retreats into nerve clusters near the spine and brain, where the immune system keeps it in check but never fully eliminates it. Lab research has shown that this dormant virus can be coaxed back into active replication when certain cellular signals weaken, particularly when growth-factor support drops or specific enzyme pathways are disrupted in neurons.
1PLoS Pathogens. An In Vitro Model of Latency and Reactivation of Varicella Zoster Virus in Human Stem Cell-Derived NeuronsIn everyday life, the trigger is usually a decline in the part of the immune system that specifically patrols for this virus. As you age, that surveillance weakens naturally. Your body produces fewer of the specialized immune cells that kept the virus boxed in during your twenties and thirties. Chronic diseases that become more common with age, such as diabetes, heart failure, and lung disease, further erode immune function and raise the odds.
2PubMed Central. Herpes Zoster: Risk Factors for Occurrence, Complications, and Recurrence with a Focus on Immunocompromised PatientsA global systematic review of 69 studies found that shingles incidence ranged from roughly 3 to 20 cases per 1,000 people, with a clear trend: rates climbed with each decade of life.
3PubMed Central. A systematic literature review of herpes zoster incidence worldwideShingles in Children and Young Adults
Although shingles is overwhelmingly an older person’s disease, it does occur in children and young adults. Case reports have documented shingles even in infants during the first few months of life, typically after the baby was exposed to varicella-zoster virus in the womb.
4American Journal of Diseases of Children. Herpes Zoster in Early InfancyOlder children and teens can also develop shingles, particularly if they had chickenpox very early in life when their immune systems were still immature. One modeling study estimated the probability of having had at least one attack of shingles before age 45 at roughly 9% for men and about 11% for women, so it is far from unheard-of in younger populations.
5BMC Infectious Diseases. The incidence of shingles and its implications for vaccination policyChildhood vaccination against chickenpox has changed this picture in an interesting way. In the United States, as successive birth cohorts received the varicella vaccine starting in the mid-1990s, shingles rates among vaccinated children dropped in a stepwise pattern. The decline showed up first among 1- to 4-year-olds around 1999, then in 5- to 9-year-olds by 2002, and continued rippling upward through older age groups as vaccinated children aged into their teens and twenties.
6The Journal of Infectious Diseases. The Impact of Universal Varicella Vaccination on Herpes Zoster Incidence in the United States: Comparison of Birth Cohorts Preceding and Following Varicella Vaccination Program LaunchChildren who receive the chickenpox vaccine can still get shingles later because the vaccine uses a live but weakened form of the virus, which also establishes latency in nerve cells. But the risk appears to be lower than for children who had natural chickenpox. If you grew up after routine chickenpox vaccination became the norm, your lifetime shingles risk is likely reduced compared with earlier generations, though researchers are still tracking this over the long term.
When Younger People Are at Higher Risk
Young people whose immune systems are compromised face a dramatically different risk profile than healthy peers the same age. A large population-based study found that people with immune-suppressing conditions had about a 51% higher risk of developing shingles overall, with the spike being far more extreme in certain groups. People who had received stem cell transplants, for example, had up to twelve times the incidence of the general population. The immunocompromised group also had more than double the rate of shingles complications, a quarter more recurrences, and nearly three times as many hospitalizations.
7PubMed Central. Herpes zoster risk and burden of disease in immunocompromised populations: a population-based study using health system integrated databases, 2009-2014Conditions that push the immune system down include HIV/AIDS, cancers of the blood like leukemia and lymphoma, autoimmune diseases treated with drugs that suppress immunity, and organ transplantation requiring lifelong anti-rejection medication. If you’re under 50 and have shingles, your doctor may want to investigate whether something is quietly weakening your immune defenses.
Women Get Shingles More Often Than Men
Across nearly every age group, women develop shingles at higher rates than men. An eight-year analysis found that women had, on average, a 28% higher age-adjusted incidence than men, with the gap widest in middle age (45 to 64) and in children under 15.
8PubMed Central. Gender difference in the incidence of shinglesA separate population-based study confirmed this pattern, finding incidence rates of roughly 3.9 per 1,000 in women compared with 2.5 per 1,000 in men, even after adjusting for other risk factors. The one consistent exception was young adults aged 15 to 24, where the gender gap narrowed or even reversed slightly.
9PubMed. Gender as an independent risk factor for herpes zoster: a population-based prospective studyA worldwide meta-regression analysis confirmed that the sex difference in shingles rates was most pronounced at younger ages (such as the 50-to-59 bracket) and shrank at older ages, suggesting that whatever biological or behavioral factors drive the gap become less relevant as the immune system declines equally in both sexes with advanced age.
10PubMed Central. Meta-Regression of Herpes Zoster Incidence WorldwideResearchers haven’t pinpointed exactly why women are more susceptible. Leading theories involve hormonal differences in immune regulation and the possibility that women are more likely to seek medical attention for the rash, leading to higher diagnosed rates. But the gap persists even in studies using hospitalization records, where the severity of the episode is less ambiguous, so reporting bias alone doesn’t explain it.
Postherpetic Neuralgia and Why Age Matters So Much
Shingles is unpleasant at any age, but the main reason doctors emphasize its seriousness in older adults is postherpetic neuralgia, or PHN. This is pain that lingers for months or even years after the rash has healed, caused by nerve damage from the viral outbreak. The risk of PHN rises sharply with age, especially between 50 and 79, where each additional decade of age roughly doubles the odds in some analyses.
11PubMed Central. Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort studyA systematic review and meta-analysis of risk factors confirmed that older age was the most consistent predictor of PHN, with individual studies reporting risk estimates ranging from about a 22% to more than a threefold increase per additional decade.
12PubMed Central. A systematic review and meta-analysis of risk factors for postherpetic neuralgiaBeing female, having diabetes, or having chronic lung or heart conditions also raises PHN risk independently of age.
13PubMed. Impact of postherpetic neuralgia: A six year population-based analysis on people aged 50 years or olderPHN can be debilitating. The burning, stabbing, or electric-shock-like pain may persist even when nothing is touching the skin, and it often disrupts sleep, mood, and daily activities. Standard pain medications frequently don’t resolve it. In a Latin American study, the total cost per shingles episode was more than double for patients who developed PHN compared with those who didn’t, with indirect costs like lost work and caregiver time driving much of the difference.
14PubMed. Economic Burden of Herpes Zoster (“culebrilla”) in Latin AmericaYoung people who get shingles rarely develop PHN. This is one reason shingles in your twenties, while uncomfortable, is usually a self-limited nuisance, whereas the same disease at 70 can become a months-long ordeal.
Eye Involvement at Different Ages
Shingles can affect any nerve path, but when it hits the branch of the trigeminal nerve that serves the eye and forehead, it’s called herpes zoster ophthalmicus, or HZO. Roughly 4 to 20% of all shingles cases involve this nerve, and about half of those go on to cause actual eye disease, including inflammation of the cornea, conjunctiva, or interior of the eye.
15PubMed Central. Herpes Zoster Ophthalmicus: Presentation, Complications, Treatment, and PreventionAs with shingles in general, the incidence of HZO climbs with age. In one population study, the rate in people 65 and older was about five times higher than in the rest of the population, and older HZO patients were more likely to develop postherpetic neuralgia and serious corneal complications.
16PubMed Central. Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation StudyYounger patients with HZO aren’t off the hook, though. A comparative study found that the most common decade of onset for eye-involving shingles was the fifties, and younger patients actually experienced more frequent recurrent flares and a specific complication called pseudodendrites. Older patients, meanwhile, had higher rates of postherpetic neuralgia and corneal nerve damage. The majority of patients in both groups were still using steroid eye drops three years after the initial episode, underscoring how persistent eye-related shingles can be regardless of age.
17PubMed. Herpes zoster ophthalmicus: comparison of disease in patients 60 years and older versus younger than 60 yearsDoes Being Around Chickenpox Protect You From Shingles?
An intriguing hypothesis in shingles research is the “exogenous boosting” idea: that being exposed to children with chickenpox gives adults a periodic immune boost against the dormant virus, delaying shingles. If true, this would mean widespread childhood chickenpox vaccination could inadvertently raise shingles rates in adults by reducing those natural booster encounters.
18PubMed. Varicella-zoster virus vaccination under the exogenous boosting hypothesis: two ethical perspectivesThere is some evidence for this immune boost on an individual level. A UK study using electronic healthcare data found that adults who lived with a child who developed chickenpox were about a third less likely to get shingles within two years, and the protective effect persisted for up to two decades.
19PubMed Central. Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare dataAt the population level, however, the expected wave of extra shingles cases after varicella vaccination programs were introduced hasn’t clearly materialized. A systematic review and meta-analysis examining countries that introduced chickenpox vaccination found no conclusive evidence that vaccination caused a population-level increase in shingles rates among unvaccinated age groups. Shingles rates had already been rising before vaccine programs began, making it difficult to separate the vaccine’s possible effect from the pre-existing trend. The review’s conclusion was that even if exogenous boosting exists as a biological phenomenon, its effect on population-wide shingles rates may be too small to detect.
20Clinical Infectious Diseases. Systematic Review and Meta-analysis of Chickenpox Vaccination and Risk of Herpes Zoster: A Quantitative View on the “Exogenous Boosting Hypothesis”For practical purposes, this means you shouldn’t count on exposure to kids with chickenpox as a shingles-prevention strategy. If you’re of an age or risk profile where shingles is a concern, vaccination is the only well-established method of reducing your risk.
When Shingles Doesn’t Look Like Shingles
Most people picture shingles as a painful, blistering rash in a band on one side of the body, and that is the classic presentation. But a less common form called zoster sine herpete involves viral reactivation without any visible rash at all. In these cases, people may experience severe pain, headache, or other neurological symptoms and go through extensive workups before anyone thinks to test for the varicella-zoster virus. In one reported case, a 43-year-old woman presented with a severe headache and sharp flank pain; the diagnosis of varicella-zoster meningitis was made only after spinal fluid testing revealed viral DNA.
21BMC Infectious Diseases. Zoster Sine Herpete: two unusual cases of varicella-zoster reactivation with atypical complaints of acute chest pain and severe headacheThis form matters because it can mimic heart attacks, strokes, and other emergencies. Without a rash to tip off clinicians, the diagnosis is frequently delayed. Anyone with unexplained unilateral nerve pain, especially if they have a history of chickenpox or known immune suppression, should be aware that shingles without a rash is a real possibility.
Vaccine Eligibility and the Age Threshold
In the United States, the recombinant shingles vaccine (Shingrix) is recommended for adults 50 and older, as well as for adults 19 and older who are immunocompromised. The age cutoff reflects where the risk-benefit math tips decisively: shingles incidence, complication rates, and the severity of postherpetic neuralgia all accelerate after 50. The vaccine is more than 90% effective at preventing shingles in the first few years after vaccination, and effectiveness remains strong for at least seven to ten years based on follow-up data available so far.
If you’re a healthy 35-year-old, you technically can get shingles, but the vaccine isn’t approved or recommended for you because your risk of shingles and especially of serious complications is low enough that the public-health benefit doesn’t justify broad vaccination. If you’re under 50 but have an immune-suppressing condition, the calculus changes, which is why the immunocompromised recommendation starts at 19.
Lifetime Risk by the Numbers
Estimates of lifetime shingles risk for someone who had chickenpox land in the range of roughly one in three. Modeling data suggests that for a 45-year-old man who has already avoided shingles to that point, the remaining lifetime risk is about 22%; for a 45-year-old woman, it’s about 32%.
5BMC Infectious Diseases. The incidence of shingles and its implications for vaccination policyThe sex gap in these numbers aligns with the epidemiological data showing women are consistently more affected. And the estimates don’t account for vaccination, which substantially reduces the risk for those who receive it. So while the raw lifetime odds are surprisingly high, they represent a worst-case scenario for someone who never gets vaccinated and lives a full lifespan. One way to think about it: shingles isn’t a rare curiosity. If you’ve had chickenpox and live long enough, the odds are roughly those of flipping two coins and getting both heads. The virus is patient, and age is its greatest ally.